RRAS2 |
RIN1 |
||
---|---|---|---|
Gene Name | related RAS viral (r-ras) oncogene homolog 2 | Ras and Rab interactor 1 | |
Image | No pdb structure | ||
Gene Ontology Annotations | Cellular Component | ||
Molecular Function | |||
Biological Process | |||
Pathways | |||
Drugs | |||
Diseases | |||
GWAS |
|
|
|
Protein-Protein Interactions | 29 interactors: ACVR1 AHSG ARAF ARHGEF2 BMPR1B CREB3 FNTB LGALS4 MLLT4 PAWR PGGT1B PIK3R1 PTPN1 RABAC1 RAF1 RALGDS RAPGEF1 RAPGEF3 RAPGEF4 RASGRF1 RASIP1 RASSF5 RIN1 SMAD3 SMAD4 SMURF2 TRAF2 TRAF3 XRCC6 | 15 interactors: ABL1 ABL2 CALCOCO2 ERBB2 ERBB3 HRAS LZTS2 MLLT4 RAB5A RAB5B RALGDS RRAS2 YWHAB YWHAE YWHAZ | |
Entrez ID | 22800 | 9610 | |
HPRD ID | 02518 | 05813 | |
Ensembl ID | ENSG00000133818 | ENSG00000174791 | |
Uniprot IDs | B7Z5Z2 P62070 | Q13671 | |
PDB IDs | 2ERY | ||
Enriched GO Terms of Interacting Partners? |
|
|
|
Tagcloud ? | abcc12
braf
dabrafenib
deregulated
deserve
detoxification
discover
exploratory
highlighted
invasiveness
klf17
melanoma
mtefd1
nqo1
peaks
rbm10
responder
responders
seldi
silico
slain1
strongest
surrogates
tox3
tspo2
v600
vemurafenib
z
zbtb44
|
||
Tagcloud (Difference) ? | abcc12
braf
dabrafenib
deregulated
deserve
detoxification
discover
exploratory
highlighted
invasiveness
klf17
melanoma
mtefd1
nqo1
peaks
rbm10
responder
responders
seldi
silico
slain1
strongest
surrogates
tox3
tspo2
v600
vemurafenib
z
zbtb44
|
||
Tagcloud (Intersection) ? |